Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 1COHANCE LIFESCIENCES LIMITED Hyderabad IN
02 1NEULAND LABORATORIES LIMITED Hyderabad IN
03 1AKTINOS PHARMA PRIVATE LIMITED Hyderabad IN
04 1Choongwae Pharma Corporation Seoul
05 1HETERO DRUGS LIMITED Hyderabad IN
06 2JANSSEN PHARMACEUTICA NV Beerse BE
07 1Janssen Pharmaceutical Ltd County Cork IE
08 1LEE PHARMA LIMITED Hyderabad IN
09 2NOSCH LABS PRIVATE LIMITED Hyderabad IN
10 2QUIMICA SINTETICA S.A. Alcala De Henares ES
11 2SMS PHARMACEUTICALS LIMITED Hyderabad IN
12 1STYRAX PHARMA PRIVATE LIMITED Visakhapatnam IN
13 1TIANISH LABORATORIES PRIVATE LIMITED Hyderabad IN
14 1VASUDHA PHARMA CHEM LIMITED Hyderabad IN
15 1W. R. GRACE & CO.-CONN. Columbia US
01 14Itraconazole
02 1Itraconazole, Bachupally site
03 1Itraconazole, Method 1
04 1Itraconazole, Method 2 (alternative synthesis)
05 1Itraconazole, Process II
06 1Itraconazole, Unit-IV
01 2Belgium
02 12India
03 1South Korea
04 2Spain
05 2U.S.A
01 3Expired
02 14Valid
03 2Withdrawn by Holder
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Certificate Number : R1-CEP 2014-165 - Rev 02
Status : Valid
Issue Date : 2023-04-04
Type : Chemical
Substance Number : 1335
Certificate Number : R1-CEP 2003-220 - Rev 06
Status : Valid
Issue Date : 2021-09-07
Type : Chemical
Substance Number : 1335
Certificate Number : CEP 2022-317 - Rev 00
Status : Valid
Issue Date : 2024-11-19
Type : Chemical
Substance Number : 1335
Certificate Number : R1-CEP 1999-196 - Rev 04
Status : Valid
Issue Date : 2021-07-29
Type : Chemical
Substance Number : 1335
Certificate Number : R1-CEP 1999-092 - Rev 07
Status : Valid
Issue Date : 2017-02-07
Type : Chemical
Substance Number : 1335
Certificate Number : R1-CEP 2011-283 - Rev 00
Status : Valid
Issue Date : 2018-05-28
Type : Chemical
Substance Number : 1335
Certificate Number : CEP 2018-173 - Rev 01
Status : Valid
Issue Date : 2023-10-12
Type : Chemical
Substance Number : 1335
Certificate Number : R1-CEP 1999-139 - Rev 03
Status : Valid
Issue Date : 2016-12-09
Type : Chemical
Substance Number : 1335
Certificate Number : R0-CEP 2019-105 - Rev 00
Status : Valid
Issue Date : 2022-10-17
Type : Chemical
Substance Number : 1335
Certificate Number : R0-CEP 2020-265 - Rev 02
Status : Valid
Issue Date : 2023-02-03
Type : Chemical
Substance Number : 1335
A Itraconazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Itraconazole, including repackagers and relabelers. The FDA regulates Itraconazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Itraconazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Itraconazole manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Itraconazole supplier is an individual or a company that provides Itraconazole active pharmaceutical ingredient (API) or Itraconazole finished formulations upon request. The Itraconazole suppliers may include Itraconazole API manufacturers, exporters, distributors and traders.
click here to find a list of Itraconazole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Itraconazole CEP of the European Pharmacopoeia monograph is often referred to as a Itraconazole Certificate of Suitability (COS). The purpose of a Itraconazole CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Itraconazole EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Itraconazole to their clients by showing that a Itraconazole CEP has been issued for it. The manufacturer submits a Itraconazole CEP (COS) as part of the market authorization procedure, and it takes on the role of a Itraconazole CEP holder for the record. Additionally, the data presented in the Itraconazole CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Itraconazole DMF.
A Itraconazole CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Itraconazole CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Itraconazole suppliers with CEP (COS) on PharmaCompass.
We have 14 companies offering Itraconazole
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?